Literature DB >> 1120958

Biliary excretion of colchicine.

A L Hunter, C D Klaassen.   

Abstract

After intravenous administration of 3H-colchicine (0.2 mg/kg) to rats, 68 percent was excreted in the feces in 48 hours suggesting bile might be the major route of excretion for colchicine. Rats with cannulated bile ducts excreted 50 percent of a 2 mg/kg dose into the bile within 2 hours; half of this was colchicine, and the rest was desmethylcolchicine and more polar metabolites. Colchicine was excreted into the bile of the rat against a bile/plasma concentration gradient of 800 which resulted from a liver/plasma ratio of 15 and a bile/liver ratio of 60. The biliary excretion of colchicine varied widely among the hamster, dog and rabbit. Of the administered colchicine, 32, 20 and 16 percent were excreted by the hamster, dog and rabbit, respectively, within 2 hours. There was also a species difference in the percentage of the radioactivity present in bile as the parent drug. In the hamster, dog and rabbit, the percentage of radioactivity excreted into the bile as colchicine was 45, 34 and 72 percent, respectively. These species excreted colchicine into the bile against a bile/plasma gradient ranging from 19 to 870. Partition of these gradients between liver/plasma and bile/liver ratios demonstrated that both ratios were greater than one, suggesting that colchicine is excreted by an active process. The liver/bile gradient was always the larger of the two ratios.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120958

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Pharmacokinetics/bioavailability of colchicine in healthy male volunteers.

Authors:  G Achtert; J M Scherrmann; M O Christen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Oct-Dec       Impact factor: 2.441

2.  Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation.

Authors:  Jui-Hsia Weng; Peter David Koch; Harding Luan; Ho-Chou Tu; Kenichi Shimada; Iris Ngan; Richard Ventura; Ruomu Jiang; Timothy J Mitchison
Journal:  Nat Metab       Date:  2021-04-12

3.  Effect of colchicine on polymerization of tubulin from rats, mice, hamsters and guinea-pigs.

Authors:  T J Fitzgerald; D G Mayfield
Journal:  Experientia       Date:  1976-01-15

Review 4.  The microtubule cytoskeleton in cardiac mechanics and heart failure.

Authors:  Matthew A Caporizzo; Benjamin L Prosser
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 49.421

5.  Effect of antimitotic agent colchicine on carbon tetrachloride toxicity.

Authors:  V C Rao; H M Mehendale
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

6.  Ultrastructure of mouse incisor ameloblasts after vascular perfusion with colchicine.

Authors:  H Akita; M Kagayama
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

7.  Colchicine intoxication: a report of two suicide cases.

Authors:  Abdulsamet Erden; Hatice Karagoz; Hasan Hüseyin Gümüscü; Samet Karahan; Mustafa Basak; Fatma Aykas; Kadir Bulut; Ali Cetinkaya; Deniz Avci; Orhan Kürsat Poyrazoglu
Journal:  Ther Clin Risk Manag       Date:  2013-12-05       Impact factor: 2.423

8.  Activated charcoal significantly reduces the amount of colchicine released from Gloriosa superba in simulated gastric and intestinal media.

Authors:  Shukry Zawahir; Indika Gawarammana; Paul I Dargan; Mahfoudh Abdulghni; Andrew H Dawson
Journal:  Clin Toxicol (Phila)       Date:  2017-05-23       Impact factor: 4.467

9.  Microtubules orchestrate local translation to enable cardiac growth.

Authors:  Emily A Scarborough; Keita Uchida; Maria Vogel; Noa Erlitzki; Meghana Iyer; Sai Aung Phyo; Alexey Bogush; Izhak Kehat; Benjamin L Prosser
Journal:  Nat Commun       Date:  2021-03-11       Impact factor: 14.919

10.  Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity.

Authors:  R S Mangipudy; P S Rao; H M Mehendale
Journal:  Environ Health Perspect       Date:  1996-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.